PERRANPORTH SURGERY
PERRANCOOMBE, PERRANPORTH
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 12 | 13 | 92.3% | |
| CKD 4 | 2008 | 91 | 122 | 74.6% | |
| CKD 5 | 2009 | 6 | 7 | 85.7% | |
| CKD 5 | 2010 | 5 | 5 | 100.0% | |
| CKD 5 | 2011 | 4 | 5 | 80.0% | |
| CKD 5 | 2012 | 4 | 5 | 80.0% | |
| CKD 5 | 2013 | 4 | 4 | 100.0% | |
| CKD003 | 2014 | 3 | 3 | 100.0% | |
| CKD003 | 2015 | 3 | 3 | 100.0% | |
| NM84 | 2016 | 5 | 11 | 45.5% | |
| NM84 | 2017 | 5 | 13 | 38.5% | |
| NM84 | 2018 | 5 | 12 | 41.7% | |
| NM84 | 2019 | 6 | 13 | 46.2% | |
| NM84 | 2020 | 4 | 11 | 36.4% | |
| NM84 | 2022 | 5 | 8 | 62.5% |
